Loading...

A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report

BACKGROUND: Patients with anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung cancer (NSCLC) are now preferentially treated with tyrosine kinase inhibitors (TKIs). However, patients treated with ALK inhibitors end up with acquired resistance. CASE PRESENTATION: We present a patient with...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: Kashima, Jumpei, Okuma, Yusuke, Hishima, Tsunekazu
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5066989/
https://ncbi.nlm.nih.gov/pubmed/27785052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S112833
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!